QGEN Qiagen NV

$45.32

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 12/31/2025

About Qiagen NV

QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.

Website: https://www.qiagen.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1015820
Address
HULSTERWEG 82, PL VENLO, NL
Valuation
Market Cap
$8.80B
P/E Ratio
107.13
PEG Ratio
0.94
Price to Book
2.47
Performance
EPS
$0.38
Dividend Yield
2.94%
Profit Margin
4.23%
ROE
2.27%
Technicals
50D MA
$39.80
200D MA
$43.06
52W High
$47.96
52W Low
$37.63
Fundamentals
Shares Outstanding
216M
Target Price
$49.23
Beta
0.62

QGEN EPS Estimates vs Actual

Estimated
Actual

QGEN News & Sentiment

Dec 29, 2025 • MarketBeat SOMEWHAT-BULLISH
Burney Co. Purchases Shares of 38,699 Qiagen N.V. $QGEN
Burney Co. acquired 38,699 shares of Qiagen N.V. (NYSE:QGEN) in the third quarter, valued at approximately $1.73 million. Other institutional investors like MAI Capital Management and Farther Finance Advisors also increased their holdings in Qiagen. The company is scheduled for a 19-for-20 reverse stock split on January 8th and recently beat Q3 earnings and revenue estimates.
Dec 27, 2025 • MarketBeat NEUTRAL
Qiagen (NYSE:QGEN) Shares Set to Reverse Split on Thursday, January 8th
Qiagen (NYSE:QGEN) is scheduled to undergo a 19-20 reverse stock split before the market opens on January 8th, with shareholder share counts adjusting after the market close on January 7th. The company recently reported $0.61 EPS on $532.6 million in revenue, exceeding analyst estimates, and currently has a "Hold" consensus rating from analysts with an average target price of $49.61. Institutional investors hold approximately 70% of Qiagen's stock.
Dec 25, 2025 • 富途牛牛 SOMEWHAT-BEARISH
Qiagen NV To Carry Out 19-for-20 Reverse Stock Split On January 8th, 2026
Qiagen NV (QGEN.US) is set to perform a 19-for-20 reverse stock split, with shares trading on a split-adjusted basis from January 8th, 2026. On December 23rd, the stock closed at $45.61 with a market capitalization of $9.89 billion. A reverse stock split consolidates existing shares but does not directly impact a company's total value, often signaling distress.
Dec 24, 2025 • MarketBeat NEUTRAL
Qiagen N.V. $QGEN Shares Sold by Voya Investment Management LLC
Voya Investment Management LLC significantly reduced its stake in Qiagen N.V. ($QGEN) during the third quarter, selling 141,669 shares, though institutional investors still hold a substantial portion of the company. Analyst sentiment remains mixed, with both "overweight" and "neutral" ratings issued recently, while Qiagen reported better-than-expected Q3 earnings and revenue. The stock currently trades in the mid-$40s with a market capitalization of approximately $10.14 billion.
Dec 21, 2025 • MarketBeat SOMEWHAT-BULLISH
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen
Wall Street Zen upgraded Qiagen (NYSE:QGEN) from a "hold" to a "buy" rating on Sunday, December 21, 2025. Despite this upgrade, the consensus among analysts remains a "hold" with an average price target of $49.61. Qiagen recently surpassed quarterly earnings and revenue estimates, showcasing modest year-over-year revenue growth.
Dec 20, 2025 • Sahm BULLISH
Qiagen’s US$500 Million Synthetic Buyback Might Change The Case For Investing In Qiagen (QGEN)
QIAGEN has announced a US$500 million synthetic share repurchase, combining a direct capital repayment with a reverse stock split, intended to reduce its share count by 5% by early January 2026. This action surpasses its prior commitment to return $1 billion to shareholders by 2028 and prompts a re-evaluation of the investment case, which now emphasizes the company's ability to expand recurring consumables revenue and manage future acquisitions given its improved shareholder return framework.
Sentiment Snapshot

Average Sentiment Score:

0.161
50 articles with scored sentiment

Overall Sentiment:

Bullish

QGEN Reported Earnings

Aug 05, 2025
Jun 30, 2025 (Post market)
0.0 Surprise
  • Reported EPS: $0.60
  • Estimate: $0.60
  • Whisper:
  • Surprise %: 0.0%
May 07, 2025
Mar 31, 2025 (Post market)
0.04 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.51
  • Whisper:
  • Surprise %: 7.8%
Feb 05, 2025
Dec 31, 2024 (Post market)
-0.01 Surprise
  • Reported EPS: $0.61
  • Estimate: $0.62
  • Whisper:
  • Surprise %: -1.6%
Nov 06, 2024
Sep 30, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $0.59
  • Estimate: $0.56
  • Whisper:
  • Surprise %: 5.4%
Jul 31, 2024
Jun 30, 2024 (Post market)
0.04 Surprise
  • Reported EPS: $0.57
  • Estimate: $0.53
  • Whisper:
  • Surprise %: 7.5%
Apr 29, 2024
Mar 31, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $0.37
  • Estimate: $0.35
  • Whisper:
  • Surprise %: 5.7%
Feb 06, 2024
Dec 31, 2023 (Post market)
0.0 Surprise
  • Reported EPS: $0.57
  • Estimate: $0.57
  • Whisper:
  • Surprise %: 0.0%
Oct 30, 2023
Sep 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $0.53
  • Estimate: $0.51
  • Whisper:
  • Surprise %: 3.9%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.01 Surprise
  • Reported EPS: $0.54
  • Estimate: $0.53
  • Whisper:
  • Surprise %: 1.9%

Financials